Free Shipping on orders over € 299.99
€216.00
Liraglutide
Peptide
0.6-1.8 mg/day
Minimal
Low
Monitoring of blood glucose and hemoglobin A1c levels
NN2211
May help reduce blood pressure in patients with type 2 diabetes
Victoza, Saxenda
1 pen x 3 ml
Store in a refrigerator (2В°C to 8В°C), protect from light, do not freeze
C172H265N43O51
Glucagon-like peptide-1 (GLP-1) receptor agonist
Lowers blood glucose levels
Approximately 13 hours
Typically initiated at 0.6 mg per day, titrated up to 1.2 mg or 1.8 mg depending on the patient's response and tolerability
Not applicable
Improves glycemic control in type 2 diabetes, promotes weight loss
Nausea, diarrhea, vomiting, constipation, reduced appetite, risk of pancreatitis
Not typically used for performance enhancement
Novo Nordisk
There are no reviews yet.
Your email address will not be published. Required fields are marked *
Your Rating Rate… Perfect Good Average Not that bad Very Poor
Your Review *
Name *
Email *
Save my name, email, and website in this browser for the next time I comment.
There are no reviews yet.